A-Alpha Bio has created an AI and synthetic biology-enabled workflow to enable rapid discovery and optimization of therapeutic antibodies. For each project, their AI model is tailored to provide focused predictions that match the unique therapeutic requirements. To do that, they first need a wet-lab-validated training dataset that captures the vast sequence space of specific antibody-target interactions. Generating this data requires precise, unbiased DNA libraries of hundreds of thousands of sequences, supplied by Twist Bioscience.

^{Results are specific to the institution where they were obtained and may not reflect the results achievable at other institutions. For research use only, not for use in diagnostic procedures.}